The San Diego-based pharmaceutical company has five approved products internationally, covering erectile dysfunction (Vitaros), side effects of cancer therapy (Totect and Granisol), coronary artery disease (Nitromist) and dry mouth (Aquoral). After a series of successes in strategic partnerships, acquisitions, peer review and clinical data in Q3, the company is garnering some serious attention.
Apricus Bio VP Edward Cox discusses the future of drug delivery technology in the rapidly expanding world of personalized medicine.
The introduction of delivering a drug on film might be the best thing since sliced bread. Similar to breath enhancement strips, this edible film technology is in studies to be used for erectile dysfunction, migraine, insomnia, bipolar disorder, and pain management!
An disorder frequently associated with ED is Peyronie’s disease.
Pharmaceutical company VIVUS has initiated an open label safety study of the investigational drug avanafil in males with erectile dysfunction.
Copyright © 2024 | WordPress Theme by MH Themes